nad has been researched along with carfilzomib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, LF; Iqbal, MN; Mahfuz, AMUB; Stambuk Opazo, F | 1 |
1 other study(ies) available for nad and carfilzomib
| Article | Year |
|---|---|
Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Klebsiella pneumoniae; Molecular Docking Simulation; Molecular Dynamics Simulation; Mycobacterium tuberculosis; NAD; Oligopeptides | 2022 |